SEC Tracker
Get the app
INCY · XBRL financial data

Incyte financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (INCY's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers1,013*8811,0441,1381,179*1,0531,2161,3661,507*1,2731,6741,557
Cost of revenue70*61778688*737999121*105105109
Research and development444*4291,138573466*437495507611*5165171,792
Selling, general and administrative294*300306309327*326331329390*328352364
Operating income (loss)187*92(478)146302*205530444336*301698(708)
Interest incomeyear only47411921*23252731*343832
Interest expense1*0110*1111*111
Other income (expense)50*455024(106)*8746*361
Income tax expense (benefit)70*675550113*761535891*4016696
Net income (loss)201*170(445)106201*158405424299*303586(785)
Earnings per share, basic USD per share0.90*0.76(2.04)0.55—0.822.092.171.52*1.522.92(3.86)
Earnings per share, diluted USD per share0.89*0.75(2.04)0.54—0.802.042.111.46*1.472.81(3.86)
Weighted average shares, basic millions of shares224*224218193193*194194196197*199200203
Weighted average shares, diluted millions of shares226*227218196201*198199201204*207208203

Balance sheet

CSV

Fiscal quarters (INCY's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents3,2133,3469871,3041,6881,9421,9552,4553,0983,4613,9823,276
Marketable securities443504462467————————
Inventory63641017059648383101116113134
Prepaid and other current assets183189208205169212296369318301253296
Total current assets4,6454,8492,5672,8093,2393,5073,6444,2785,0245,4846,0275,521
Property and equipment, net752720762773763765799799731720709701
Goodwill156156156156156156156156133133133133
Total assets6,7827,1364,6625,0125,4445,7495,8216,3306,9587,3397,8737,287
Accounts payable110164148179197196241172210229250235
Accrued liabilities9361,1021,0341,1281,2121,3768579481,0321,092870967
Total current liabilities1,2401,3961,3371,5021,6421,7201,2791,3391,5151,4901,3121,438
Lease liability, non-current14———17———15———
Total liabilities1,5921,7411,6651,8411,9972,0821,6501,6791,7901,7161,5281,644
Retained earnings (accumulated deficit)160330(1,380)(1,274)(1,073)(915)(510)(86)2145171,103318
Total stockholders' equity5,1905,3942,9973,1713,4483,6684,1714,6515,1675,6236,3445,643
Total liabilities and equity6,7827,1364,6625,0125,4445,7495,8216,3306,9587,3397,8737,287
Common shares outstanding (cover page) millions of shares225225193193194194195196199200203204

Cash flows

CSV

Fiscal quarters (INCY's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)201*170(445)106201*158405424299*303586(785)
Stock-based compensation60*6057*78*72*6165*62*62*6467*70*
Depreciation and amortization22*2222*23*23*2223*24*24*2426*24*
Net cash from operating activities148*219(576)*311*381*26645*559*543*369508*(675)*
Net cash from investing activities(155)*(73)214*38*(21)*1(19)*(47)*(37)*(88)(52)*(44)*
Share repurchases0*——0*0*——0*0*———
Net cash from financing activities0*(12)(1,997)*(32)*20*(13)(11)*(13)*138*8565*14*
Net change in cash(14)*133(2,359)*317*384*25413*500*643*363521*(707)*

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Incyte3,2761,557(675)*203.8M 10-QSep 30, 2026
Charles River Laboratories International200983254*47.9M 10-QSep 26, 2026
Medpace Holdings705716217*28.0M 10-QSep 30, 2026
Iqvia Holdings2,2494,428825*164.8M 10-QSep 30, 2026
UL Solutions1,016823215*not reported 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.